Atlas Trials

Metastatic Conjunctival Melanoma

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Metastatic Conjunctival Melanoma

RecordFirmDate
Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer (NCT05098210)Fred Hutchinson Cancer Center2022-06-09

Track Metastatic Conjunctival Melanoma automatically

Every clearance here is in the API, with alerts when new ones post.